Section 4: Clinical Pharmacy Services

4CPS-167

EVALUATION OF PHARMACEUTICAL INTERVENTIONS: IMPROVEMENT PLANS (submitted in 2019)

4CPS-166

ANALYSIS OF THE MAINTENANCE RATE OF LONG ACTING INJECTABLE ANTIPSYCHOTIC TREATMENT IN OUTPATIENTS (submitted in 2019)

4CPS-165

ANALYSIS OF ANTIBIOTIC CONSUMPTION IN A NURSING HOME (submitted in 2019)

4CPS-164

A SAFE HANDLING HAZARDOUS DRUGS STRATEGY TO IMPROVE THE SAFETY OF HEALTH PROFESSIONALS: REDUCING EXPOSURE BY MEDICAL PRESCRIPTION REVIEW IN NURSING HOMES (submitted in 2019)

4CPS-163

CLINICAL PHARMACIST RESIDENCE IN AN INTENSIVE CARE UNIT: SCOPE AND RELEVANCE (submitted in 2019)

4CPS-162

PHARMACEUTICAL INTERVENTIONS IN DRUGS PROVIDED TO THE OUTPATIENT HOSPITAL PHARMACY (submitted in 2019)

4CPS-161

PHARMACIST INTERVENTIONS IN A HOSPITAL AT HOME UNIT (submitted in 2019)

4CPS-160

MANAGEMENT OF DRUGS IN PATIENTS WITH SWALLOWING DIFFICULTIES IN A PUBLIC RESIDENTIAL CARE HOME: ROLE OF THE HOSPITAL PHARMACIST (submitted n 2019)

4CPS-159

MANAGEMENT OF COMMUNITY ACQUIRED PNEUMONIA AT A TERTIARY CARE TEACHING HOSPITAL (submitted in 2019)

4CPS-158

PRESCRIBING TRENDS OF ADALIMUMAB AND ETANERCEPT BIOSIMILAR DRUGS IN A THIRD LEVEL HOSPITAL (submitted in 2019)

4CPS-157

INTRAVENOUS BIOSIMILAR PRESCRIBING TRENDS IN A THIRD LEVEL SPANISH HOSPITAL (submitted in 2019)

4CPS-156

ANALYSIS OF THE EFFECTIVENESS AND SAFETY OF DARATUMUMAB IN MONOTHERAPY IN ADULT PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA (submitted in 2019)

4CPS-155

REAL LIFE EXPERIENCE OF HOME CARE ADMINISTRATION OF 5-AZACITIDINE AND DOMICILIARY MANAGEMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (submitted in 2019)

4CPS-154

POTENTIALLY INAPPROPRIATE MEDICATION FOR ELDERLY HOSPITALISED PATIENTS IN A TRAUMA AND ORTHOPAEDIC SURGERY DEPARTMENT (submitted in 2019)

4CPS-153

INTENSIFICATION IN BIOLOGICAL TREATMENT IN ULCERATIVE COLITIS (submitted in 2019)

Pages